These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19916891)

  • 1. Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin.
    Andersen AS; Berthelsen JG; Bergholt T
    Acta Obstet Gynecol Scand; 2010; 89(1):15-21. PubMed ID: 19916891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study.
    Galambosi PJ; Kaaja RJ; Stefanovic V; Ulander VM
    Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):154-9. PubMed ID: 22658765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.
    Kominiarek MA; Angelopoulos SM; Shapiro NL; Studee L; Nutescu EA; Hibbard JU
    J Perinatol; 2007 Jun; 27(6):329-34. PubMed ID: 17443203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy.
    Knol HM; Schultinge L; Veeger NJ; Kluin-Nelemans HC; Erwich JJ; Meijer K
    Thromb Res; 2012 Sep; 130(3):334-8. PubMed ID: 22475315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tinzaparin use in pregnancy: an international, retrospective study of the safety and efficacy profile.
    Nelson-Piercy C; Powrie R; Borg JY; Rodger M; Talbot DJ; Stinson J; Greer IA
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):293-9. PubMed ID: 21945573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
    Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
    Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
    Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetric outcome with low molecular weight heparin therapy during pregnancy.
    Donnelly J; Byrne J; Murphy K; McAuliffe F
    Ir Med J; 2012 Jan; 105(1):27-9. PubMed ID: 22397211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
    Galambosi PJ; Ulander VM; Kaaja RJ
    Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison].
    Rath W; Tsikouras P; von Tempelhoff GF
    Z Geburtshilfe Neonatol; 2016 Jun; 220(3):95-105. PubMed ID: 27315397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
    Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
    J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
    Sun P; Dong DN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density.
    Galambosi P; Hiilesmaa V; Ulander VM; Laitinen L; Tiitinen A; Kaaja R
    Thromb Res; 2016 Jul; 143():122-6. PubMed ID: 27236710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?
    Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
    J Thromb Haemost; 2011 Mar; 9(3):473-80. PubMed ID: 21232006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
    Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A
    Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].
    Rath W
    Z Geburtshilfe Neonatol; 2010 Dec; 214(6):217-28. PubMed ID: 21207321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].
    Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
    Ned Tijdschr Geneeskd; 2011; 155():A3433. PubMed ID: 21527059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.